FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/05/2022
Back to search
Official data from USPTO
DEXPLORER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
09/05/2022
Trademark type
Combined
Nice classes
9, 42
Filing date
11/27/2020
Registration date
03/22/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/22/2022
Last transaction
03/22/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
KR
Examiner
NOVAKOVIC, MIROSLAV
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "DEXPLORER" in purple centered above Korean characters in purple.
Holders and representatives
Holders
Medicare Pharmaceuticals Inc.
Representatives
Leigh Ann Lindquist SUGHRUE MION, PLLC
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Recorded computer software for drug development using artificial intelligence; recorded computer software for analytics for clinical trial datafor data collectiondata analysisdata storingdata miningdata generationmachine learningall in drug discovery and drug development fields; recorded computer software for simulating drug development; recorded computer software for the analysis of data in the medical and biotechnology fields using algorithm for deep learning; recorded computer software based on artificial intelligence for image analysis and data analysis in the medical and biotechnology fields; recorded computer software for analysing medical diagnostic information; computer operating programsrecorded; recorded computer software for data processing; recorded medical software for pregnancy education; recorded medical software for uploadingstoring and submitting medical images for computer-aided diagnosis of respiratory medical conditions affecting humansproviding patient diagnosis risk assessmentsworkflow management and billing in the field of healthcare; recorded medical software for recordingprocessingtransmittingreceiving data for medical diagnostic and monitoring purposes; recorded medical software for aiding in the detection and diagnostics of congestive heart failure; recorded software for artificial intelligence conversionanalysisprocessingstorage and transmission
Class 42
Drug discovery services; research for medical products; scientific research and technical consulting on the testinspection and research of medical products; development of pharmaceutical preparations and medicines; drug discovery services based on artificial intelligence; software design and development; computer software consultancy; application service provider featuring software for localwide and global communications networks which allow users to connect remote computers and computer networks together to exchange healthcare information and data; software as a service featuring software based on artificial intelligence for the analysis of deep learning image and data in the medical and biotechnology fields; platform as a service featuring computer software platform for data collectiondata analysisdata storage and data mining used in the healthcare and biotechnology fields; software as a service featuring software for data collectiondata analysisdata storage and data mining used in the healthcare and biotechnology fields; design of computer software for healthcare and medical institutions; installation and maintenance of computer software for healthcare and medical institutions; technical consultation related to medical researchbiotechnology data analysis and software development; technical consultation related to medical data analysis for research purposes; technical consultation related to software development in the medical field; research and development of computer software platform in the artificial intelligence field; software development for artificial intelligence service; drug discovery services through computer modeling methods; development of computer software for big data processing
Publications
History of USPTO decisions and trademark events.
34 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/12/2022
FIMP
FINAL DISPOSITION PROCESSED
08/11/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/22/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
03/22/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/04/2022
PUBO
PUBLISHED FOR OPPOSITION
01/04/2022
GPNX
NOTIFICATION PROCESSED BY IB
01/01/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/15/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/15/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/15/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
12/02/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/02/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
12/02/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/18/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/18/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/18/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/15/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/15/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/15/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/15/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/15/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/15/2021
RFNT
REFUSAL PROCESSED BY IB
06/13/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/27/2021
RFRR
REFUSAL PROCESSED BY MPU
05/27/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/25/2021
CNRT
NON-FINAL ACTION WRITTEN
05/24/2021
DOCK
ASSIGNED TO EXAMINER
05/12/2021
MAFR
APPLICATION FILING RECEIPT MAILED
02/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/04/2021
Continuous trademark protection
Get notified about every new filing that threatens DEXPLORER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.